Clinical Trial: Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

Sponsor and Collaborators
National Cancer Institute (NCI)

Contact
Contact: NCI Referral Office
1-888-NCI-1937
ncicssc@mail.nih.gov


Continue Reading

Principal Investigator

ClinicalTrials.gov Identifier
NCT01092182